---
title: "Rockchip: Products based on RISC-V architecture have been mass-produced"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261572149.md"
description: "On October 17th, Rockchip stated on the interactive platform that the company's chips are currently primarily based on ARM architecture, but new products based on RISC-V architecture have been launched and mass-produced, and it will continue to develop products based on RISC-V architecture in the future"
datetime: "2025-10-17T08:05:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261572149.md)
  - [en](https://longbridge.com/en/news/261572149.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261572149.md)
---

# Rockchip: Products based on RISC-V architecture have been mass-produced

On October 17th, Rockchip stated on the interactive platform that the company's chips are currently primarily based on the ARM architecture, but new products based on the RISC-V architecture have been launched and mass-produced, and it will continue to develop products based on the RISC-V architecture in the future

### Related Stocks

- [603893.CN](https://longbridge.com/en/quote/603893.CN.md)

## Related News & Research

- [FACTBOX-Here are the Democrats taking early steps in potential 2028 White House bids](https://longbridge.com/en/news/286890348.md)
- [TRUMP: VENEZUELAN OIL COMING TO TEXAS, LOUISIANA AND ALASKA](https://longbridge.com/en/news/287097512.md)
- [Nearly Half Of French Voters May Support National Rally, And Immigration Is A Major Concern](https://longbridge.com/en/news/287013257.md)
- [PharmEasy's parent has a new playbook: Profit first, growth second](https://longbridge.com/en/news/286890424.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)